Skip to main content
Log in

Cost-effectiveness of sirolimus-eluting stents in AMI 'debatable'

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Canoui-Poitrine F, Jeanblanc G, Alberti C, Armoogum P, Cebrian A, Carrié D, Henry P, Teiger E, Slama M, Spaulding C, Durand-Zaleski I.Cost effectiveness of sirolimus-eluting stents compared with bare metal stents in acute myocardial infarction: insights from the TYPHOON trial. Applied Health Economics and Health Policy 7: 19-29, No. 1, Jan 2009

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cost-effectiveness of sirolimus-eluting stents in AMI 'debatable'. Pharmacoecon. Outcomes News 583, 6 (2009). https://doi.org/10.2165/00151234-200905830-00011

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905830-00011

Keywords

Navigation